The importance of diversity in clinical studies

People of all ages, races and ethnicities—who are either healthy or have pre-existing conditions—participate in clinical trials research all over the world. You can too.

Global Regulatory Consulting Solutions

Making Clinical Trials Available to All

Clinical trials are an essential and fundamental component of bringing any new drug or treatment to market. The purpose of clinical trials is to measure the efficacy (meaning the ability to achieve an intended result) and safety (identifying, evaluating, and minimizing associated risks) of new treatments. Without patients on those trials, new drugs don't get developed. So, ensuring that these trials work for all – regardless of gender, ethnicity, age, or affordability – is a really important consideration the drug developers take when designing trials.

How diabetes drugs are used for weight loss

The rate of obesity worldwide has almost tripled since 1975, leading to a global epidemic of obesity and overweight. As of 2016, reportedly 39% of adults around the world are overweight, and 13% have obesity. In the United States alone, more than 2 in 5 adults are affected by obesity and nearly 1 in 3 are overweight. The obesity epidemic has serious consequences for public health, as obesity and overweight are associated with an increased risk for diabetes, stroke, heart disease, and certain cancers.

What Should You Know About Dementia?

Dementia affects more than 55 million people around the world. It is an important cause of death and disability among older adults, and its global cost reaches 1.3 trillion U.S. dollars annually.

System advisory re the Crowdstrike computer outage

How stroke awareness can improve outcomes

Stroke is a leading cause of death and disability

Helping to Decode Colorectal Cancer

If you are visiting this page because you, or someone you know, is living with, or facing, the possibility of having colorectal cancer (CRC for short), you’ve come to the right place. The first thing that you should know is that treatment for CRC today is not like in the past. Yes, the part of the body affected is the same. Yes, CRC is still a group of abnormal cells that have grown into what you might call a mass or a tumor. BUT the difference lies in what we know about the actual makeup of the tumor.

Discovery drug metabolism and pharmacokinetics (DMPK)

Quantification of the monoclonal antibody pembrolizumab in human blood collected via volumetric adsorptive microsampling (VAMS) technology and utilizing LC-MS/MS detection